Last reviewed · How we verify

NCT05870787: MEDIATOR

iMproving thE DIagnostics And Treatment Of ceRvical Precancer

Completed Last updated 10 February 2026
What this trial tests

trial testing Swede score colposcopy in Cervical Dysplasia in 929 participants. Completed in 13 December 2024.

Timeline
1 March 2023
Primary endpoint
6 December 2024
13 December 2024

Quick facts

Lead sponsorUniversity of Aarhus
StatusCompleted
Study typeOBSERVATIONAL
Enrollment929
Start date1 March 2023
Primary completion6 December 2024
Estimated completion13 December 2024
Sites7 locations across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

Adults 23 to 99, female only, with Cervical Dysplasia or Cervical Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cervical cancer screening is important as it enables identification of women at increased risk of the disease, but high-quality diagnostics of screen-positive women and effective treatment of those with precancer are critical in preventing progression to cancer. With the current transition from cytology-based to primary human papillomavirus (HPV)-screening and a growing proportion of HPV-vaccinated women, diagnostics of screen-positive women will become more challenging in the decades to come. Thus, there is a need to explore how to improve diagnostics while ensuring a low number of unnecessary procedures such as colposcopy and the collection of multiple cervical biopsies. The overall purposes are: Purpose 1: To investigate the diagnostic accuracy of cervical precancer when using a colposcopic scoring system in the diagnostic work-up of screen-positive women. Purpose 2: To investigate the performance of a colposcopic scoring system to identify women without cervical precancer in whom collection of biopsies can be safely omitted.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Assessment of a colposcopic scoring system (Swedescore) to reduce the number of cervical biopsies: a protocol for a clinical multicentre non-randomised intervention study in Denmark.
    Knudsen AS, Randrup TH, Kesmodel US, Booth B, et al · · 2024 · cited 2× · PMID 39675832 · DOI 10.1136/bmjopen-2024-085382

Verify or expand the search:

Other recruiting trials for Cervical Dysplasia

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05870787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing